[Study on genomic imprinting of IGF2 in breast cancer].
暂无分享,去创建一个
OBJECTIVE
To explore the imprinting status of the insulin like growth factor-2 associated with the development of breast cancer.
METHODS
The samples of heterozygotes of IGF-2 was identified by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) in 47 breast cancers tissue and their adjacent tissues, and then imprinting status of IGF-2 in these heterozygosis were detected by RT-PCR-RFLP.
RESULT
Losses of imprinting of IGF2 were found in both of the cancer tissues and adjacent normal breast tissue and the incidence rates of losses of printing in the adjacent tissues(79.2%) were more higher than those in the cancer tissues (50.0%), it has statistical significance (P = 0.035). If there were losses of imprinting of IGF-2 in the breast cancer tissues, then there were losses of imprinting of IGF-2 in their corresponding adjacent tissues. But If there were maintain of imprinting of IGF-2 in the breast cancer tissues, then there were losses and maintain of imprinting of IGF-2 in their corresponding adjacent tissues.
CONCLUSION
The loss of imprinting of IGF-2 could be involved in the development of breast cancer.